RETRACTION: Challenges of Combined Everolimus/Endocrine Therapy in Hormone Receptor-Positive Metastatic Breast Cancer

Por Porta, Camillo
Publicado no Oncol Rev (2014)

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Por Porta, Camillo, Paglino, Chiara
Publicado em 2010

ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics

Por Porta, Camillo, Chiellino, Silvia
Publicado no Ann Transl Med (2016)

Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

Por Porta, Camillo, Paglino, Chiara, Mutti, Luciano
Publicado em 2008

Targeting PI3K/Akt/mTOR Signaling in Cancer

Por Porta, Camillo, Paglino, Chiara, Mosca, Alessandra
Publicado em 2014

Modifying sunitinib schedule in advanced kidney cancer patients: Reflections from the results of the renal EFFECT trial

Por Porta, Camillo, Ganini, Carlo, Paglino, Chiara
Publicado no Transl Androl Urol (2012)

Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Por Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Ganini, Carlo, Pedrazzoli, Paolo
Publicado em 2011

Insulin-like growth factor-1 signaling in renal cell carcinoma

Por Tracz, Adam F., Szczylik, Cezary, Porta, Camillo, Czarnecka, Anna M.
Publicado no BMC Cancer (2016)

Choosing the right cell line for renal cell cancer research

Por Brodaczewska, Klaudia K., Szczylik, Cezary, Fiedorowicz, Michal, Porta, Camillo, Czarnecka, Anna M.
Publicado no Mol Cancer (2016)

Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy

Por Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Canipari, Cinzia, Chen, Kristina, Neary, Maureen, Duh, Mei Sheng
Publicado em 2011

The role of the cell–cell interactions in cancer progression

Por Kamińska, Katarzyna, Szczylik, Cezary, Bielecka, Zofia F, Bartnik, Ewa, Porta, Camillo, Lian, Fei, Czarnecka, Anna M
Publicado no J Cell Mol Med (2015)

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Por Mickisch, Gerald HJ, Schwander, Björn, Escudier, Bernard, Bellmunt, Joaquim, Maroto, José P, Porta, Camillo, Walzer, Stefan, Siebert, Uwe
Publicado em 2011

Lingual metastasis from renal cell carcinoma: a case report and literature review

Por Ganini, Carlo, Lasagna, Angioletta, Ferraris, Elisa, Gatti, Patrizia, Paglino, Chiara, Imarisio, Ilaria, Morbini, Patrizia, Benazzo, Marco, Porta, Camillo
Publicado em 2012

Glomerular diseases and cancer: evaluation of underlying malignancy

Por Pani, Antonello, Porta, Camillo, Cosmai, Laura, Melis, Patrizia, Floris, Matteo, Piras, Doloretta, Gallieni, Maurizio, Rosner, Mitchell, Ponticelli, Claudio
Publicado no J Nephrol (2015)

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

Por Bertino, Pietro, Porta, Camillo, Barbone, Dario, Germano, Serena, Busacca, Sara, Pinato, Sabrina, Tassi, Giancarlo, Favoni, Roberto, Gaudino, Giovanni, Mutti, Luciano
Publicado em 2007

SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma

Por Cacciotti, Paola, Libener, Roberta, Betta, Piergiacomo, Martini, Fernanda, Porta, Camillo, Procopio, Antonio, Strizzi, Luigi, Penengo, Lorenza, Tognon, Mauro, Mutti, Luciano, Gaudino, Giovanni
Publicado em 2001

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

Por Porta, Camillo, Gore, Martin E., Rini, Brian I., Escudier, Bernard, Hariharan, Subramanian, Charles, Lorna P., Yang, Liqiang, DeAnnuntis, Liza, Motzer, Robert J.
Publicado no Eur Urol (2015)

Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results

Por Bertino, Giulia, Occhini, Antonio, Falco, Carlo Emilio, Porta, Camillo, Corbella, Franco, Colombo, Sara, Balcet, Vittoria, Morbini, Patrizia, Zappoli, Federico, Azzaretti, Andrea, Rodolico, Giuseppe, Tinelli, Carmine, Benazzo, Marco
Publicado em 2009

Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial

Por Porta, Camillo, Calvo, Emiliano, Climent, Miguel A., Vaishampayan, Ulka, Osanto, Susanne, Ravaud, Alain, Bracarda, Sergio, Hutson, Thomas E., Escudier, Bernard, Grünwald, Viktor, Kim, Dennis, Panneerselvam, Ashok, Anak, Oezlem, Motzer, Robert J.
Publicado em 2012

Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma—Analysis Using Diagnostic Nodes

Por Rothermundt, Christian, Bailey, Alexandra, Cerbone, Linda, Eisen, Tim, Escudier, Bernard, Gillessen, Silke, Grünwald, Viktor, Larkin, James, McDermott, David, Oldenburg, Jan, Porta, Camillo, Rini, Brian, Schmidinger, Manuela, Sternberg, Cora, Putora, Paul M.
Publicado no Oncologist (2015)